GlassScriptPhysician profile
Lisa Tran
NPI 1508492471
$1,299.51
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $616 · 2022: $521 · 2023: $130 · 2024: $32.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $162.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $246.32 | 2022 | |
| Scynexis, INC. | $170.18 | 2022 | |
| Abbvie INC. | $148.27 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $147.50 | 2021 | |
| Sanofi-Aventis U.S. LLC | $141.82 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $121.83 | 2021 | |
| Merck Sharp & Dohme LLC | $97.72 | 2022-2023 | Pifeltro, Delstrigo, Isentress |
| Gilead Sciences, INC. | $72.56 | 2022-2023 | |
| Janssen Biotech, INC. | $42.32 | 2022-2023 | Symtuza |
| Organon LLC | $41.18 | 2021 | |
| Stryker Corporation | $32.67 | 2024 | |
| Nobel Biocare USA | $21.44 | 2023 | Nobelactive |
| Novo Nordisk INC | $15.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.